The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  September 2017 Next

EFMC Best Poster Prizes at EFMC-ISMC 2016

The EFMC Best Poster Prizes have been granted during the XXIV International Symposium on Medicinal Chemistry (EFMC-ISMC 2016) to the following participants :

  • P036 - Dmitrii Kalinin (University of Münster, Germany)
    DESIGN, SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF PROLINE HYDROXAMATES TARGETING ZINC-DEPENDENT ENZYMES
  • P096 - Yasuhiro Imaeda (Takeda Pharmaceutical Company, Japan)
    DISCOVERY OF TAK-272: A NOVEL, POTENT AND ORALLY ACTIVE RENIN INHIBITOR
  • P132 - Nis Halland (Sanofi, Germany)
    NOVEL SMALL MOLECULE INHIBITORS OF ACTIVATED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFIa) FROM NATURAL PRODUCT ANABAENOPEPTIN
  • P192 - Geoffrey Schwertz (ETH Zurich, Switzerland)
    SHMT INHIBITION: A NEW HOPE TO DEFEAT MALARIA
  • P253 - Xavier Lucas (University of Dundee, United Kingdom)
    PROTACTING LEADS: DESIGN OF A PROTEIN SURFACE-TARGETING FRAGMENT LIBRARY
  • P334 - Jonas Kaindl (Friedrich-Alexander-University Erlangen-Nuernberg, Germany)
    STRUCTURE-GUIDED DEVELOPMENT AND MOLECULAR MODELLING OF D2R/NTS1R HETERODIMER-SELECTIVE LIGANDS
  • P444 - Arno Vermote (Ghent University, Belgium)
    POTENTIATOR DRUGS FOR BAD BUGS - HAMAMELITANNIN ANALOGUES POTENTIATE ANTIBIOTICS IN THE FIGHT AGAINST STAPHYLOCOCCUS AUREUS
  • P466 - Liam Hudson (Institute of Cancer Research, United Kingdom)
    DEVELOPMENT OF A NEW CLASS OF ALK2 INHIBITOR FOR THE STUDY OF THE MOST AGGRESSIVE PAEDIATRIC BRAIN CANCER, DIPG
  • P592 - Christian Kersten (Johannes Gutenberg University, Germany)
    SELECTIVITY DETERMINING FEATURES IN N-MYRISTOYLTRANSFERASES - A POTENTIAL DRUG TARGET WITH A HIGHLY CONSERVED BINDING SITE
  • P522 - Daniela Dengler (Friedrich-Alexander University Erlangen-Nuremberg, Germany)
    DISCOVERY OF A G-PROTEIN BIASED MU OPIOID ANALGESIC WITH REDUCED SIDE EFFECTS

Each Poster Prize consists of a Diploma and a 200€ cash prize

Photographer - Fabien Venturi
Contact: venturifab@yahoo.fr


EFMC Best Poster Prizes

To support Medicinal Chemistry and Young Medicinal Chemists, the EFMC grants at the occasion of the EFMC International Symposium on Medicinal Chemistry, the EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry and the EFMC-ACSMEDI Medicinal Chemistry Frontiers Symposium, a certain number of EFMC Best Poster Prizes.

Participating posters are reviewed by a selection team constiting of committee members and the selection is announced during the closing ceremony of the Symposium.

Each EFMC Best Poster Prize constists of a diploma and a 200€ cash prize.

 


M T W T F S S
28 29 30 31 01 02 03
04 05 06 07 08 09 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 01
All events   |  Future events

Job portal

15/09/2017
Research / Senior Scientist Medicinal Chemistry, UCB: Medicinal Chemistry, Braine - L'Alleud, Belgium
read more


15/09/2017
Principal Scientist Medicinal Chemistry, UCB: Medicinal Chemistry, Braine-L'Alleud, Belgium
read more


15/08/2017
Medicina; Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more


04/08/2017
Postdoctoral position (applied research): pharmacology, medicinal chemistry, Lucas Meyer Cosmetics - IFF group: R&D, Paris or Toulouse, France
read more


20/04/2017
Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more


Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck